White House’s Drug Plan Is Missing Some Key Details: Lisa Jarvis

There couldn’t be a more pressing or galvanizing topic for Americans than the high cost of prescription drugs. And after months of blustery talk from President Donald Trump about lowering prices and cracking down on Big Pharma, his plans are finally starting to take shape, beginning with pacts with manufacturers. But before we get too excited, consumers should demand more transparency about what they’re getting from his dealmaking — and ask who is truly benefiting from the sum of his health care actions.

Trump wisely put the issue of drug costs front and center, promising consumers a better deal than what ...